| CTRI Number |
CTRI/2025/09/095106 [Registered on: 19/09/2025] Trial Registered Prospectively |
| Last Modified On: |
18/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Dentistry |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
A study to test the benefits of a specialized toothpaste on dental health of adults |
|
Scientific Title of Study
|
Clinical research study to evaluate the efficacy of a stannous fluoride toothpaste on established dental plaque and gingivitis in adults |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Ashish Kakar |
| Designation |
Director Dental Research |
| Affiliation |
GLOBAL HEALTH RESERCH GROUP |
| Address |
DENTAL RESEARCH DEPARTMENT DIVISION ROOM NO. B1
H-8 MASJID MOTH GREATER KAILASH PART-2 NEW DELHI
South DELHI 110048 India |
| Phone |
9811081052 |
| Fax |
|
| Email |
ashish@ghrg.org |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Bhuvana Gurumurthy |
| Designation |
Assistant Manager, Clinical Innovation |
| Affiliation |
Colgate-Palmolive India Limited |
| Address |
Ground Floor, Colgate Research Centre, India Global Technology
Center, Main Street, Hiranandani Gardens, Powai, Mumbai
Mumbai MAHARASHTRA 400076 India |
| Phone |
02267096165 |
| Fax |
|
| Email |
bhuvana_gurumurthy@colpal.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bhuvana Gurumurthy |
| Designation |
Assistant Manager, Clinical Innovation |
| Affiliation |
Colgate-Palmolive India Limited |
| Address |
Ground Floor, Colgate Research Centre, India Global Technology
Center, Main Street, Hiranandani Gardens, Powai, Mumbai
Mumbai MAHARASHTRA 400076 India |
| Phone |
02267096165 |
| Fax |
|
| Email |
bhuvana_gurumurthy@colpal.com |
|
|
Source of Monetary or Material Support
|
| Colgate Palmolive Company 909 River Rd, Piscataway, NJ 08854, USA |
|
|
Primary Sponsor
|
| Name |
Colgate-Palmolive Company |
| Address |
909 River Rd, Piscataway, NJ 08854, USA |
| Type of Sponsor |
Other [FMCG - Global] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Ashish Kakar |
GLOBAL HEALTH RESEARCH GROUP |
H-8 MASJID MOTH DENTAL RESEARCH DEPARTMENT DIVISION ROOM NO. B1 GREATER KAILASH PART-2 NEW DELHI 110048 South DELHI |
9811081052
ashish@ghrg.org |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| GOOD SOCIETY ETHICAL RESEARCH |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K051||Chronic gingivitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Commercially available toothpaste |
Whole mouth brushing with a toothpaste, 2 times/day for 1 minute each time for the duration of the study |
| Intervention |
Test product with active |
Whole mouth brushing with a toothpaste, 2 times/day for 1 minute each time for the duration of the study |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
Potential subjects must meet ALL of the following criteria:
Males and females, between 18-70 years of age;
Informed Consent Form signed and availability for the duration of the study;
Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study. Examples include heart problems, valve/hip replacements, etc);
Willingness to provide information related to their medical history;
Minimum of 15 uncrowned permanent natural teeth (excluding third molars);
Initial mean gingivitis index of at least 1 as determined by the use of the Loe and Silness Gingival Index and mean Plaque Index score of at least 1.5 determined by the Turesky modification of the Quigley-Hein Plaque Index;
Availability for the duration of the study.
|
|
| ExclusionCriteria |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Case Record Numbers |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Gingivitis (Loe and Silness Index) |
Baseline, 3 months and 6 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Plaque (Turesky modification of the Quigley-Hein Plaque Index) |
Baseline, 3 months and 6 months |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
29/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The objective of this clinical research study is to evaluate the efficacy of a specialized toothpaste on established dental plaque and gingivitis in adults. This is a phase III, single center, randomized, parallel and double blinded study conducted on about 100 subjects in the age group between 18 to 70 years.
The subjects will be exposed to either of 2 different test products for a period of 6 months with a treatment regimen of whole mouth brushing twice daily for 2 minutes. |